Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A known ✓ | P04350 | 2/20 | 0.45 |
| ▸ | TUBB known ✓ | P07437 | 2/20 | 0.45 |
| ▸ | TUBA3C known ✓ | P0DPH7 | 2/20 | 0.45 |
| ▸ | TUBA1B known ✓ | P68363 | 2/20 | 0.45 |
| ▸ | TUBA4A known ✓ | P68366 | 2/20 | 0.45 |
| ▸ | TUBB4B known ✓ | P68371 | 2/20 | 0.45 |
| ▸ | TUBB3 known ✓ | Q13509 | 2/20 | 0.45 |
| ▸ | TUBB2A known ✓ | Q13885 | 2/20 | 0.45 |
| ▸ | TUBB8 known ✓ | Q3ZCM7 | 2/20 | 0.45 |
| ▸ | TUBA3E known ✓ | Q6PEY2 | 2/20 | 0.45 |
| ▸ | TUBA1A known ✓ | Q71U36 | 2/20 | 0.45 |
| ▸ | TUBA1C known ✓ | Q9BQE3 | 2/20 | 0.45 |
| ▸ | TUBB6 known ✓ | Q9BUF5 | 2/20 | 0.45 |
| ▸ | TUBB2B known ✓ | Q9BVA1 | 2/20 | 0.45 |
| ▸ | TUBB1 known ✓ | Q9H4B7 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | MMP1 | P03956 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL11435520 | 1.00 | CA1 (0.54) | CA1CA2MMP1MMP2MMP9 | |
| Sulfuric Acid SCHEMBL29558209 | 0.98 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| Sulfuric Acid SCHEMBL479725 | 0.98 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| Sulfuric Acid SCHEMBL11681409 | 0.89 | CA1 (0.55) | CA1CA2MMP1MMP2MMP9 | |
| Water SCHEMBL6445920 | 0.88 | ALDH1A1 (0.61) | ALDH1A1HTTLMNAL3MBTL1CYP3A4 | |
| Water SCHEMBL11435527 | 0.88 | ALDH1A1 (0.61) | ALDH1A1HTTLMNAL3MBTL1CYP3A4 | |
| Methyl Alcohol SCHEMBL28031053 | 0.86 | ALDH1A1 (0.59) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL29389101 | 0.86 | ALDH1A1 (0.64) | ALDH1A1HTTLMNAL3MBTL1CYP3A4 | |
| SCHEMBL15514306 | 0.86 | ALDH1A1 (0.64) | ALDH1A1HTTLMNAL3MBTL1CYP3A4 | |
| SCHEMBL212391 | 0.86 | ALDH1A1 (0.64) | ALDH1A1HTTLMNAL3MBTL1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103852539-B | The detection method of azo in a kind of electronic devices and components | 广州市博诺通化工技术服务有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-103852539-A | Method for detecting azo in electronic element | KUNSHAN LUODAN BIOTECHNOLOGY CO LTD | 2014-06-11 | — | — | CN | disclosed |
| US-7445877-B2 | Charge transport materials having a central disulfane linkage | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-11-04 | — | — | US | disclosed |
| US-7326506-B2 | Bridged charge transport materials having a central sulfur atom linkage | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-02-05 | — | — | US | disclosed |
| EP-1600821-B1 | Bridged charge transport materials having a central sulfur atom linkage | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-02-28 | — | — | EP | disclosed |
| EP-1529779-B1 | Organophotoreceptor with charge transport material with two N,N,N,-trisubstituted-amino groups | SAMSUNG ELECTRONICS CO LTD (KR) | 2006-12-20 | — | — | EP | disclosed |
| US-20050277038-A1 | Charge transport materials having a central disulfane linkage | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-12-15 | — | — | US | disclosed |
| US-20050266329-A1 | Bridged charge transport materials having a central sulfur atom linkage | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-12-01 | — | — | US | disclosed |
| EP-1600821-A1 | Bridged charge transport materials having a central sulfur atom linkage | Samsung Electronics Co., Ltd. (KR) | 2005-11-30 | — | — | EP | disclosed |
| CN-1702563-A | Bridged charge transport materials having a central sulfur atom linkage | SAMSUNG ELECTRONICS CO LTD (KR) | 2005-11-30 | — | — | CN | disclosed |
| US-20050089780-A1 | Organophotoreceptor with charge transport material with two N,N,N-trisubstituted-amino groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-04-28 | — | — | US | disclosed |
| CN-1609719-A | Organophotoreceptor with charge transport material with two n,n,n-trisubstituted-amino groups | SAMSUNG ELECTRONICS CO LTD (KR) | 2005-04-27 | — | — | CN | disclosed |
| EP-1148048-A2 | Polyaromatic antiviral compositions | PHARMACIA & UPJOHN COMPANY (US) | 2001-10-24 | — | — | EP | disclosed |
| EP-1068531-A2 | LIGAND SCREENING AND DESIGN BY X-RAY CRYSTALLOGRAPHY | Abbott Laboratories (US) | 2001-01-17 | — | — | EP | disclosed |
| US-6147116-A | TOPICALLY ADMINISTERING BENZENE DERIVATIVE SUBSTITUTED WITH UREIDO-, THIOUREIDO, AND/OR SULFONAMIDO GROUPS TO TREAT HERPES | PHARMACIA & UPJOHN COMPANY (US) | 2000-11-14 | — | — | US | disclosed |
| EP-0973735-A2 | POLYAROMATIC ANTIVIRAL COMPOSITIONS | PHARMACIA & UPJOHN COMPANY (US) | 2000-01-26 | — | — | EP | disclosed |
| US-5958983-A | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY AGAINST HERPES, TOPICAL ADMINISTRATION THEM TO TREAT PATIENTS WITH HERPES; WORK BY INHIBITING THE INITIATION OF HERPES VIRAL DNA SYNTHESIS IN HOST CELLS | PHARMACIA & UPJOHN COMPANY (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1999045379-A2 | LIGAND SCREENING AND DESIGN BY X-RAY CRYSTALLOGRAPHY | ABBOTT LABORATORIES (US) | 1999-09-10 | — | — | WO | disclosed |
| WO-1999045389-A2 | LIGAND SCREENING AND DESIGN BY X-RAY CRYSTALLOGRAPHY | ABBOTT LAB (US) | 1999-09-10 | — | — | WO | disclosed |
| WO-1998045259-A2 | POLYAROMATIC ANTIVIRAL COMPOSITIONS | PHARMACIA & UPJOHN COMPANY (US) | 1998-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050266329-A1 | Bridged charge transport materials having a central sulfur atom linkage | NR2E3, NR4A2, NR2C2 | TUBB4A 2059/4885TUBB 3102/4885TUBA3C 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.